Under these conditions, reduced classical IL-6 signaling could protect from chronic inflammation and differentiation of Th17 cells, consistent our finding of reduced risk of T1D in carriers of the 358Ala allele. This evidence concerns the gene IL6 and type 1 diabetes mellitus.